Heterocyclic Anticancer Agents

Heterocyclic Anticancer Agents

€250.00*

available, immediately via download

If you require delivery outside DE, AT or CH, please use our contact form for an inquiry.

Cancer is an incredibly diverse and difficult disease to treat, and even after decades of research there is no definitive cure. Therefore, it is highly crucial to search for novel and new organic molecules with high potency, low toxicity, and low mutagenicity with selective anticancer properties that are able to overcome frequently developed resistance to available drugs. Heterocyclic anticancer agents are an important class of drugs for cancer therapies. This book explores different heterocycles and their use as anticancer therapies. Topics covered include different heterocyclic derivatives, the impact of heterocycles on anticancer agent development, and naturally occurring heterocycles.

Bimal K. Banik, Prince Mohammad Bin Fahd University, Al-Khobar, Saudi Arabia; Bubun Banerjee, Akal University, India.

ISBN 9783110735819
Article number 9783110735819
Media type eBook - ePUB
Copyright year 2022
Publisher Walter de Gruyter GmbH & Co.KG
Length 532 pages
Language English
Copy protection Digital watermarking